Trigger point injections for myofascial pain in terminal cancer: a randomized trial
- 10 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 26 (1) , 14-21
Abstract
Objective: The aim of this study was to evaluate the efficacy and safety of a single trigger point injection (TPI) of a local anesthetic for the treatment of myofascial pain syndrome (MPS) in patients with incurable cancer. Methods: This multicenter, exploratory, open-label, randomized comparative trial was conducted in five specialized palliative care departments. Hospitalized patients with incurable cancer who had been experiencing pain related to MPS were randomized to receive either a TPI of 1% lidocaine plus conventional care (TPI group) or conventional care alone (control group). The short-term efficacy and occurrence of adverse events (AEs) were compared between groups. The primary endpoint was the percentage of patients who experienced a reduction in pain scores of ≥50%, assessed using an 11-point Numerical Rating Scale, at 3 days post-intervention. Adverse events were assessed using the Common Terminology Criteria for AEs v5.0. Results: Fifty patients were enrolled, and the trial completion rate was 100%. The proportion of patients who experienced an improvement in Numerical Rating Scale pain scores of ≥50% was 70.8% (95% confidence interval, 52.4%-89.2%) in the TPI group and 0.0% in the control group; the difference was statistically significant (P < .001). In the TPI group, one case (4.2%) of Grade 1 nausea and 1 case (4.2%) of Grade 1 somnolence were reported. Conclusion: A single TPI of a local anesthetic is safe and efficacious in inducing an immediate reduction in MPS-related pain in patients with incurable cancer. Clinical trials registration number: This study was registered with the Japan Registry of Clinical Trials (approval number: jRCTs051210132) on December 16, 2021. https://jrct.niph.go.jp/en-latest-detail/jRCTs051210132. Approval of the research protocol by a Certified Review Board: The present study was approved by the Wakayama Medical University (reference number: CRB5180004. Registered 26 May 2021).Keywords
Funding Information
- Grant for Research Advancement on Palliative Medicine
- Japanese Society for Palliative Medicine (201)
This publication has 24 references indexed in Scilit:
- Clinical Characteristics of Myofascial Pain Syndrome with Psychological Stress in Patients with CancerJournal of Palliative Medicine, 2021
- Pragmatic Randomized Controlled Pilot Trial on Trigger Point Injections With 1% Lidocaine Versus Conventional Approaches for Myofascial Pain in the Emergency DepartmentThe Journal of Emergency Medicine, 2020
- Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain DisordersThe Clinical Journal of Pain, 2019
- Evidence for Dry Needling in the Management of Myofascial Trigger Points Associated With Low Back Pain: A Systematic Review and Meta-AnalysisArchives of Physical Medicine and Rehabilitation, 2018
- Factors Associated with the Efficacy of Trigger Point Injection in Advanced Cancer PatientsJournal of Palliative Medicine, 2017
- Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Chronic Pain Grade Scale (CPGS), Short Form‐36 Bodily Pain Scale (SF‐36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)Arthritis Care & Research, 2011
- Prevalence of pain in patients with cancer: a systematic review of the past 40 yearsAnnals of Oncology, 2007
- Pain Measurement Tools and Methods in Clinical Research in Palliative CareJournal of Pain and Symptom Management, 2002
- When is cancer pain mild, moderate or severe? Grading pain severity by its interference with functionPain, 1995
- Reliability of the pressure algometer as a measure of myofascial trigger point sensitivityPain, 1986